Moneycontrol
HomeNewsIndiaGovt asks 5 states including Maharashtra to monitor emerging clusters as COVID-19 cases rise

Govt asks 5 states including Maharashtra to monitor emerging clusters as COVID-19 cases rise

The Union Health Secretary has asked the five states to keep a vigil on patients with influenza-like illnesses and severe acute respiratory syndrome to detect early signs of the spread of the coronavirus infection.

June 03, 2022 / 17:53 IST
Story continues below Advertisement
Representative image (REUTERS/Danish Siddiqui)

Union Health Secretary Rajesh Bhushan on June 3 asked five states witnessing a sudden surge in COVID-19 cases to closely monitor emerging clusters.

Bhushan wrote to the state governments of Kerala, Maharashtra, Telangana, Karnataka and Tamil Nadu, instructing them to monitor emerging clusters, maintain adequate number of tests, and send samples from infected individuals for genome sequencing.

Story continues below Advertisement

ALSO READ: Coronavirus Update | Active COVID-19 cases in country rise to 21,177

Additionally, Bhushan has also asked the states to keep a vigil on patients with influenza-like illnesses and severe acute respiratory syndrome to detect early signs of the spread of the coronavirus infection.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show